Financials data is unavailable for this security.
View more
Year on year China Dasheng Biotechnology Co has grown net income from a loss of 68.00k to a gain of 4.64m primarily through revenue growth (0.00 to 16.29m). For while the costs associated with cost of goods, selling, general and administrative and debt all increased as a percentage of sales, the -- growth in revenues contributed enough to still see net income improve.
Gross margin | 47.85% |
---|---|
Net profit margin | 34.97% |
Operating margin | 33.59% |
Return on assets | 33.10% |
---|---|
Return on equity | 40.01% |
Return on investment | 41.97% |
More ▼
Cash flow in USDView more
In 2008, China Dasheng Biotechnology Co increased its cash reserves by 18.53%, or 244.00k. The company earned 4.10m from its operations for a Cash Flow Margin of 25.14%. In addition the company used 3.92m on investing activities and also paid 927.00k in financing cash flows.
Cash flow per share | 0.2663 |
---|---|
Price/Cash flow per share | 0.2565 |
Book value per share | 0.6408 |
---|---|
Tangible book value per share | 0.5924 |
More ▼